RECRUITING

Building Community Living Labs in Black Communities to Advance Prostate Health Equity and Reduce Prostate Cancer Disparities in Black Men

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This clinical trial the possibility of establishing a Community Living Labs (CoLLab) Learning Health System to facilitate access to prostate health Risk, Education, and Assessment in the Community with Help (REACH) services in Black men and compares the impact to American Legion Posts with no CoLLab set up at the individual and community levels. Cancer is the second leading cause of death for Black men and Black men are less likely to receive prostate cancer screening. CoLLab Learning Health System utilizes community health workers (CHW) that are well-trained to form a bridge between communities and clinicians. In fact, Black men who work with CHW's typically have better access to health services, gain knowledge about cancer, cancer prevention, treatment and may have better overall health outcomes. Establishing a CoLLab Learning Health System at American Legion Posts may improve access to clinical trials and prostate cancer services in Black men.

Official Title

Building Community Living Labs (CoLLab) in Black Communities with the Goal of Advancing Prostate Health Equity and Reducing Prostate Cancer Disparities in Black Men

Quick Facts

Study Start:2024-05-04
Study Completion:2027-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06541210

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * AIMS 1 AND 3: Participants must be one of the following key personnel:
  2. * Community PI (n=1),
  3. * CoLLab Program Manager (n=1)
  4. * CoLLab Site Managers (n=3)
  5. * CoLLab CAB members (n=21)
  6. * 2 Community Health Workers (CHWs) per Post site (n=6)
  7. * AIMS 1 AND 3: Between the ages of 21 and 80.
  8. * AIMS 1 AND 3: Able to complete the survey in English.
  9. * AIMS 1 AND 3: Reside in the Jacksonville, FL and/or surrounding counties.
  10. * AIMS 1 AND 3: Willing and able to consent to the study.
  11. * AIM 2: Black adult of any gender.
  12. * AIM 2: Must be between the ages of 30 and 80.
  13. * AIM 2: Able to speak English.
  14. * AIM 2: Reside in the Jacksonville, FL and/or surrounding counties.
  15. * AIM 2: Willing and able to consent to the study.
  1. * AIMS 1 AND 3: Younger than 21years or older than 80 years.
  2. * AIMS 1 AND 3: Not a resident of NE Florida. Unwilling or unable to consent to the study.
  3. * AIM 2: Younger than 30 years or older than 80 years.
  4. * AIM 2: Not a resident of NE Florida.
  5. * AIM 2: Unwilling or unable to consent to the study.

Contacts and Locations

Study Contact

Clinical Trials Referral Office
CONTACT
855-776-0015
mayocliniccancerstudies@mayo.edu
Quincy Wimberly
CONTACT
904-953-0974
Wimberly.Quincy@mayo.edu

Principal Investigator

Folakemi T. Odedina, Ph.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Folakemi T. Odedina, Ph.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-04
Study Completion Date2027-09-30

Study Record Updates

Study Start Date2024-05-04
Study Completion Date2027-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Prostate Carcinoma